Sugi Predict

Sugi Predict / Compounds / SCHEMBL21143709

SCHEMBL21143709

SCHEMBL21143709

CCOC(=O)c1ccn(-c2nc(C)cc(NC3CCC(F)(F)CC3)n2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ IDH1 O75874 2/20 0.42
▸ MAPT P10636 3/20 0.42
▸ THRB P10828 1/20 0.42
▸ KCNN2 Q9H2S1 1/20 0.38
▸ KCNN3 Q9UGI6 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ NR2F2 P24468 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ S1PR2 O95136 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19687210 0.91 KDM4E (0.42) KDM4EALDH1A1HSD17B10HPGDTP53
SCHEMBL19687377 0.90 KDM4E (0.42) KDM4EALDH1A1HSD17B10HPGDTP53
SCHEMBL19687378 0.90 KDM4E (0.42) KDM4EALDH1A1HSD17B10HPGDTP53
SCHEMBL21143885 0.89 IDH1 (0.42) KDM4EALDH1A1HPGDIDH1MAPT
SCHEMBL21143741 0.89 IDH1 (0.42) KDM4EALDH1A1HSD17B10HPGDTP53
SCHEMBL31127171 0.88 HSD17B10 (0.40) KDM4EALDH1A1HSD17B10HPGDTP53
SCHEMBL19687508 0.88 HSD17B10 (0.40) KDM4EALDH1A1HSD17B10HPGDTP53
SCHEMBL19687171 0.88 IDH1 (0.45) IDH1KCNN2KCNN3KIF18ASPR
SCHEMBL31127076 0.88 IDH1 (0.45) IDH1KCNN2KCNN3KIF18ASPR
SCHEMBL21144048 0.87 KDM4E (0.38) KDM4EALDH1A1HSD17B10HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240317705-A1 POTASSIUM CHANNEL MODULATORS NOVARTIS AG (CH) 2024-09-26 — — US disclosed
US-10774064-B2 Potassium channel modulators CADENT THERAPEUTICS, INC. (US) 2020-09-15 — — US disclosed
US-10774064-B2 Potassium channel modulators CADENT THERAPEUTICS, INC. (US) 2020-09-15 — — US disclosed
US-20190218200-A1 POTASSIUM CHANNEL MODULATORS NOVARTIS AG (CH) 2019-07-18 — — US disclosed
US-20190218200-A1 POTASSIUM CHANNEL MODULATORS NOVARTIS AG (CH) 2019-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240317705-A1 POTASSIUM CHANNEL MODULATORS KCNJ11, KCNJ2, KCNJ1 KDM4E 1648/4885ALDH1A1 1320/4885HSD17B10 1483/4885
US-10774064-B2 Potassium channel modulators KCNJ11, KCNJ2, KCNJ1 KDM4E 1648/4885ALDH1A1 1320/4885HSD17B10 1483/4885
US-20190218200-A1 POTASSIUM CHANNEL MODULATORS KCNJ11, KCNJ2, KCNJ1 KDM4E 1648/4885ALDH1A1 1320/4885HSD17B10 1483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.